Ubs Asset Management Americas Inc Repare Therapeutics Inc. Transaction History

Ubs Asset Management Americas Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$12.5 - $18.13 $276,000 - $400,310	22,080 Added 18.05%	144,424 $2.12 Million
Q3 2022 Nov 14, 2022	SELL	$11.57 - $15.59 $213,223 - $287,308	-18,429 Reduced 13.09%	122,344 $1.48 Million
Q2 2022 Aug 12, 2022	SELL	$8.45 - $14.84 $44,083 - $77,420	-5,217 Reduced 3.57%	140,773 $1.97 Million
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $132,167 - $254,114	-11,614 Reduced 7.37%	145,990 $2.08 Million
Q4 2021 Feb 14, 2022	SELL	$19.66 - $28.11 $56,915 - $81,378	-2,895 Reduced 1.8%	157,604 $3.32 Million
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $141,919 - $194,524	-5,520 Reduced 3.32%	160,499 $4.21 Million
Q2 2021 Aug 16, 2021	SELL	$30.1 - $34.85 $471,727 - $546,169	-15,672 Reduced 8.63%	166,019 $5.18 Million
Q1 2021 May 14, 2021	BUY	$25.89 - $44.46 $128,103 - $219,988	4,948 Added 2.8%	181,691 $5.58 Million
Q4 2020 Mar 01, 2021	SELL	$23.42 - $39.5 $246,518 - $415,777	-10,526 Reduced 5.62%	176,743 $6.06 Million
Q3 2020 Nov 13, 2020	BUY	$21.55 - $33.92 $54,629 - $85,987	2,535 Added 1.37%	187,269 $5.76 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $5.69 Million - $6.09 Million	184,734 New	184,734 $5.73 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $119M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.